Monday, November 16, 2020

Moderna Vaccine Has 94.5% Efficacy, Trial Analysis Shows

-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Record IPO

  SpaceX Seeks $75 Billion in Record IPO to Fund AI, Launch